Patent · US Active

Methods and materials for treating cancer

US12257286B2 · kind B2 · utility

0Cited by
125References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2019
Grant dateMar 25, 2025
Priority date
Expiry dateJun 30, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/70596
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This document relates to methods and materials involved in treating mammals having a cancer (e.g., a cancer having one or more CD19 positive extracellular vesicles (EVs) and/or one or more small EVs in the tumor microenvironment). For example, methods of treating a mammal having a blood cancer including one or more CD19 positive EVs and/or one or more small EVs in the blood by administering one or more cancer immunotherapies (e.g., one or more chimeric antigen receptor (CAR) T-cell therapies) to the mammal are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.